Caspase-3 Protein

Caspase-3 Protein

Overview

Pathway Diagram

```mermaid
flowchart TD
Caspase["Caspase<br/>Protease Enzyme"]

ROS_gene["ROS<br/>Oxidative Stress"]
AMPK_gene["AMPK<br/>Energy Sensor"]
HSP70_gene["HSP70<br/>Heat Shock Protein"]
PPARG_gene["PPARG<br/>Metabolic Regulator"]

RIPK1_gene["RIPK1<br/>Death Receptor Kinase"]
WNT_gene["WNT<br/>Signaling Pathway"]
STAT3_gene["STAT3<br/>Transcription Factor"]

GSDME_protein["GSDME<br/>Gasdermin E"]
IL1B_protein["IL1B<br/>Interleukin-1beta"]

PANoptosis_process["PANoptosis<br/>Programmed Cell Death"]
Neurodegeneration_process["Neurodegeneration<br/>Neural Loss"]
ALS_disease["ALS<br/>Motor Neuron Disease"]

ROS_gene -->|"activates"| Caspase
AMPK_gene -->|"regulates"| Caspase
HSP70_gene -->|"protects"| Caspase
PPARG_gene -->|"modulates"| Caspase

RIPK1_gene -->|"activates"| Caspase
WNT_gene -->|"regulates"| Caspase
STAT3_gene -->|"interacts"| Caspase

Caspase -->|"cleaves"| GSDME_protein
Caspase -->|"activates"| IL1B_protein

Caspase -->|"triggers"| PANoptosis_process
Caspase -->|"drives"| Neurodegeneration_process
Neurodegeneration_process -->|"leads_to"| ALS_disease

GSDME_protein -->|"promotes"| PANoptosis_process
IL1B_protein -->|"enhances"| Neurodegeneration_process

style Caspase fill:#006494
style HSP70_gene fill:#1b5e20
style PPARG_gene fill:#1b5e20
style ROS_gene fill:#ef5350
style RIPK1_gene fill:#ef5350
style WNT_gene fill:#4a1a6b
style AMPK_gene f

Caspase-3 Protein

Overview

Pathway Diagram

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Caspase-3 Protein</th>
</tr>
<tr>
<td class="label">Disease</td>
<td>Primary Trigger</td>
</tr>
<tr>
<td class="label">ALS</td>
<td>SOD1, TDP-43</td>
</tr>
<tr>
<td class="label">HD</td>
<td>Mutant huntingtin</td>
</tr>
<tr>
<td class="label">Stroke</td>
<td>Ischemia</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Caspase-3 Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target. [@yuan2010]

Caspase-3 (Cysteine-ASPartic protease-3), also known as CPP32, apopain, or SCA-1, is a member of the cysteine-aspartic protease (caspase) family that plays a central and critical role in programmed cell death (apoptosis). In the context of neurodegenerative diseases, caspase-3 activation represents a crucial executer of neuronal death pathways in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and related disorders [1](https://pubmed.ncbi.nlm.nih.gov/12551937/). [@das2015]

Molecular Function and Biochemistry

Enzyme Classification and Structure

Caspase-3 belongs to the family of aspartate-specific cysteine proteases, classified as an effector caspase (along with caspase-6 and caspase-7), functioning downstream of initiator caspases (caspase-8, -9, -10) in the apoptosis cascade. The systematic name is EC 3.4.22.56, and the gene is located on chromosome 4q33 [1](https://pubmed.ncbi.nlm.nih.gov/12551937/). [@hyman2014]

The enzyme exists as an inactive zymogen (procaspase-3, 32 kDa) that requires proteolytic activation to generate the active heterotetramer. This activation involves cleavage at specific aspartic acid residues and subsequent dimerization of the p17/p12 subunits. [@damelio2012]

Domain Architecture

Caspase-3 contains distinct structural domains: [@friedlander2003]

The three-dimensional structure reveals a classic caspase fold with a central six-stranded β-sheet flanked by α-helices, with the active site formed at the interface between the two subunits. [@onyango2005]

Substrate Specificity and Recognition

Caspase-3 demonstrates high specificity for the tetrapeptide sequence DEXD (Asp-Glu-X-Asp), with optimal cleavage occurring after DXXD motifs. The S1 pocket shows absolute specificity for aspartate, while the S2-S4 pockets accommodate various amino acids, with preference for glutamic acid at S2 [1](https://pubmed.ncbi.nlm.nih.gov/12551937/). [@mattson2000]

Over 200 cellular substrates have been identified, classified into several functional groups: [@wolfe2013]

Structural and Cytoskeletal Proteins [@henderson2016]

• Actin and tubulin: Essential for cytoskeletal integrity
• Lamin A/C: Nuclear envelope maintenance
• Vimentin: Intermediate filament structure
• Spectrin: Membrane skeleton

• PARP (poly ADP-ribose polymerase): DNA repair
• DNA-PKcs: Non-homologous end joining
• Topoisomerase II: DNA topology

• PKC isoforms: Signal transduction
• STAT1: Transcription factor
• AKT: Cell survival kinase

• Bcl-2: Mitochondrial outer membrane permeabilization regulator
• Mcl-1: Anti-apoptotic Bcl-2 family member
• XIAP: Direct caspase inhibitor

• p21cip1: Cyclin-dependent kinase inhibitor
• Wee1: Cell cycle kinase

Activation Mechanism

Caspase-3 activation occurs through a tightly regulated proteolytic cascade:

This activation cascade ensures that caspase-3 activation occurs only after upstream death signals have been triggered, providing an important checkpoint in the cell death program.

Role in Neurodegenerative Diseases

Alzheimer's Disease

In Alzheimer's disease, caspase-3 contributes to multiple pathological processes, making it a central player in neuronal death [2](https://pubmed.ncbi.nlm.nih.gov/14638856/):

Amyloid-β-Induced Apoptosis
Amyloid-β42 oligomers trigger caspase-3 activation through multiple interconnected pathways:

• Mitochondrial dysfunction: Aβ42 causes mitochondrial membrane potential loss, cytochrome c release, and subsequent activation of the intrinsic apoptosis pathway
• Calcium dysregulation: Aβ42 elevates intracellular calcium levels, activating calcium-dependent proteases that contribute to caspase activation
• Reactive oxygen species (ROS) generation: Oxidative stress from Aβ42 damages mitochondria and directly activates caspase-3
• Neurotrophic factor signaling disruption: Aβ42 interferes with BDNF and other survival signals

Tau Cleavage and Pathology
Caspase-3 cleaves tau protein at Asp421, generating a truncation product with enhanced pathogenic properties [3](https://pubmed.ncbi.nlm.nih.gov/12591068/):

• Aggregation promotion: The Δtau421 fragment has increased propensity for aggregation and filament formation
• Propagation enhancement: Caspase-cleaved tau is more efficient at seeding tau pathology in recipient neurons
• Microtubule disruption: Truncated tau more readily dissociates from microtubules
• NFT formation: The fragment incorporates into neurofibrillary tangles

Synaptic Loss and Dysfunction
Caspase-3-mediated cleavage of synaptic proteins contributes to early synaptic dysfunction, a hallmark of AD:

• Synaptic vesicle proteins: Synaptophysin, synaptotagmin cleavage disrupts neurotransmitter release
• Postsynaptic density proteins: PSD-95, NMDA receptor subunit cleavage affects synaptic plasticity
• Cytoskeletal proteins: Spine structure proteins are degraded

• Neurofibrillary tangle formation: Colocalization of active caspase-3 with NFTs
• Neuronal loss: Particularly in vulnerable brain regions (hippocampus, entorhinal cortex, basal forebrain)
• Clinical disease severity: Cognitive decline correlates with caspase-3 activity
• Progression prediction: May predict progression from MCI to AD

Parkinson's Disease

In Parkinson's disease, caspase-3 plays multiple interconnected roles in dopaminergic neuron death [4](https://pubmed.ncbi.nlm.nih.gov/15962738/):

α-Synuclein Cleavage
Caspase-3 cleaves α-synuclein at multiple sites, generating pathogenic fragments:

• Asp119 cleavage: Generates a fragment that enhances aggregation propensity
• Asp123 cleavage: Produces a toxic truncation product that disrupts membrane integrity
• Asp125 cleavage: Contributes to pathogenic aggregation and Lewy body formation

• Seed aggregation of full-length α-synuclein
• Form toxic oligomers that disrupt cellular homeostasis
• Promote Lewy body formation
• Facilitate prion-like propagation between neurons

Mitochondrial Dysfunction and Dopaminergic Neuron Vulnerability
Dopaminergic neurons are particularly vulnerable to caspase-3-mediated apoptosis due to their unique characteristics:

• High metabolic demand: Substantia nigra neurons have high ATP requirements
• Mitochondrial complex I deficiency: Characteristic of PD
• Elevated ROS production: Dopamine metabolism generates reactive species
• Calcium homeostasis disruption: Pacemaker activity leads to calcium flux

• G2019S mutation: Enhances caspase-3 activation through kinase-dependent mechanisms
• R1441C/H/G mutants: Alter apoptotic thresholds in neurons
• Kinase activity effects: LRRK2 kinase activity directly influences pro-apoptotic signaling

• Parkin cleavage: Caspase-3 can cleave parkin, potentially disrupting its E3 ligase function
• Mitophagy disruption: Caspase-3 activation affects mitochondrial quality control
• Accumulation of damaged mitochondria: Leads to increased ROS and further damage

Amyotrophic Lateral Sclerosis (ALS)

In ALS, caspase-3 activation contributes to progressive motor neuron death [5](https://pubmed.ncbi.nlm.nih.gov/12421763/):

SOD1 Mutations
Mutant Cu/Zn superoxide dismutase (SOD1) proteins trigger caspase-3 activation through:

• Direct interaction with mitochondria
• Endoplasmic reticulum stress induction
• Oxidative stress generation
• Excitotoxicity amplification

• Alters caspase-3 expression and activation
• Contributes to transcriptional dysregulation
• Promotes motor neuron vulnerability
• Affects RNA processing of apoptosis-related genes

• Oxidative stress: ROS from mutant SOD1 and mitochondrial dysfunction
• Excitotoxicity: Glutamate-induced calcium influx
• Mitochondrial dysfunction: Energy failure and cytochrome c release
• Neuroinflammation: Activated microglia release pro-apoptotic factors

Huntington's Disease

Caspase-3 plays complex and sometimes paradoxical roles in Huntington's disease:

Mutant Huntingtin Cleavage
Mutant huntingtin (mHTT) protein is cleaved by caspase-3 at multiple sites:

• Asp513 cleavage: Generates toxic fragments that accumulate in the cytoplasm
• Asp552 cleavage: Contributes to pathogenesis through gain-of-toxic-function
• Asp586 cleavage: Produces aggregation-prone fragments

• Accumulate in the nucleus
• Disrupt transcriptional regulation
• Form nuclear inclusions
• Cause widespread transcriptional dysregulation

Stroke and Ischemic Injury

Caspase-3 is a major mediator of neuronal death after stroke and cerebral ischemia:

Reperfusion Injury
Blood flow restoration paradoxically increases damage:

• Calcium overload activates caspases
• ROS burst triggers intrinsic pathway
• Inflammation amplifies cell death

• NMDA receptor overactivation
• Calcium influx
• Mitochondrial dysfunction

• Reduces infarct size
• Improves functional outcomes
• Extends treatment window

Therapeutic Targeting

Pharmacological Inhibitors

Several classes of caspase-3 inhibitors have been developed for neuroprotection [6](https://pubmed.ncbi.nlm.nih.gov/17656456/):

Peptide Inhibitors

• DEVD-CHO: Cell-permeable tetrapeptide (Ac-DEVD-CHO)
• Z-DEVD-FMK: Irreversible inhibitor, fluorescent version available
• Ac-DEVD-CHO: Selective for caspase-3 over other caspases
• VEID-CHO: Alternative sequence preference

• Small molecule hydrazides
• Pyrazolone derivatives
• Quinoline-based inhibitors
• Pyrroloindole derivatives

• Quercetin: Flavonoid with multiple cellular effects
• Curcumin derivatives: Enhanced stability and potency
• Epigallocatechin-3-gallate (EGCG): Polyphenol with neuroprotective properties
• Resveratrol: SIRT1 activator with anti-apoptotic effects

Challenges in Drug Development

Despite promising preclinical data, significant challenges remain:

Alternative Strategies

Gene Therapy Approaches

• Dominant-negative caspase-3 mutants
• siRNA-mediated knockdown
• CRISPR-based gene editing
• Anti-sense oligonucleotides

• Death receptor blockers
• BCL-2 family modulators
• Mitochondrial protectants
• Antioxidants

• Viral vector delivery to specific neurons
• Antibody-drug conjugates
• Exosome-mediated delivery
• Focused ultrasound enhancement

Biomarker Potential

Caspase-3 activity serves as a potential biomarker for neurodegeneration [6](https://pubmed.ncbi.nlm.nih.gov/17656456/):

Cerebrospinal Fluid (CSF) Biomarkers

• Elevated caspase-3 in AD, PD, and ALS patients
• Correlates with disease severity
• May predict progression from MCI to AD
• Can be combined with other biomarkers

Blood-Based Biomarkers

• Peripheral blood mononuclear cell (PBMC) caspase-3
• Platelet caspase-3 activation
• Plasma caspase-3 cleavage products

Imaging Biomarkers

• Caspase-3-targeted PET ligands in development
• Fluorescent probes for intraoperative imaging
• Near-infrared dyes for in vivo imaging

Research Directions and Gaps

Recent Advances (2020-2024)

Critical Knowledge Gaps

• Cell-type specific functions of caspase-3 in the brain
• Temporal dynamics of activation in vivo
• Biomarker validation in large clinical cohorts
• Clinical trials of caspase inhibitors
• Optimal timing and delivery methods
• Distinguishing protective vs. harmful caspase-3 functions

Future Research Priorities

• Development of brain-penetrant caspase-3 inhibitors
• Identification of neuroprotective vs. pro-death caspase-3 functions
• Biomarker development for patient stratification
• Combination therapies targeting multiple pathways
• Gene therapy approaches
• Stem cell-based therapies with caspase modulation

Interactions and Signaling Networks

Protein-Protein Interactions

Caspase-3 interacts with numerous proteins in the apoptosis network:

Inhibitors

• XIAP (X-linked inhibitor of apoptosis protein): Direct binding and inhibition
• c-FLIP (cellular FLICE-like inhibitory protein): Blocks caspase-8 activation
• Bcl-2 family anti-apoptotic proteins: Mitochondrial pathway regulation

• Apaf-1 (apoptotic protease-activating factor 1): Forms apoptosome with cytochrome c
• Cytochrome c: Released from damaged mitochondria
• Smac/DIABLO: Neutralizes XIAP

• FADD: Death receptor signaling
• TRADD: TNFR1 signaling
• RAIDD: PIDDosome formation

Signaling Pathway Integration

Caspase-3 serves as a central hub integrating multiple cell death pathways:

• Extrinsic pathway: Amplifies death receptor signaling through bid cleavage
• Intrinsic pathway: Executes mitochondrial apoptosis
• ER stress pathway: Mediates UPR-induced cell death
• DNA damage pathway: Executes p53-dependent apoptosis
• Mitophagy pathway: Links to mitochondrial quality control

Conclusion

Caspase-3 represents a central executor of neuronal death in neurodegenerative diseases. Its roles in AD, PD, ALS, HD, and stroke are multifaceted, involving substrate cleavage, protein aggregation, synaptic dysfunction, and neuroinflammation. While significant progress has been made in understanding its functions, significant challenges remain in translating this knowledge into effective therapies. The development of brain-penetrant, selective caspase-3 inhibitors and the identification of reliable biomarkers remain key research priorities for the neurodegenerative disease field.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Biochemical Kinetics and Catalytic Mechanism

Catalytic Mechanism

Caspase-3 employs a classic cysteine protease catalytic mechanism:

[
The active site contains:- Oxyanion hole: Stabilize- S1 pocket: Absolute specificity for aspartate

• S2-S4 pockets: Determine substrate sequence specificity

Kinetic Parameters

• Kcat: ~1-10 s⁻¹
• Km: ~1-50 μM (substrate-dependent)
• Kcat/Km: ~10⁴-10⁵ M⁻¹s⁻¹

pH and Temperature Dependencies

• Optimal pH: 7.0-7.5
• Temperature optimum: 37°C
• pH stability: 5.5-8.5

Regulation of Caspase-3 Activity

Transcriptional Regulation

Caspase-3 expression is regulated at multiple levels:

• Promoter elements: p53, E2F, and other transcription factors
• Alternative splicing: Multiple isoforms with different activities
• mRNA stability: AU-rich elements in 3' UTR

Post-Translational Modifications

Phosphorylation

• Ser residues: Phosphorylation can modulate activity
• Kinases: PKA, CK2, and other kinases may phosphorylate caspase-3

• S-nitrosylation of Cys163 inhibits activity
• Occurs in NO-mediated neuroprotection

• N-linked glycosylation affects stability
• May protect from proteasomal degradation

Cellular Localization

Caspase-3 distribution in neurons:

• Cytoplasmic pool: Primarily localized in cytoplasm
• Mitochondrial translocation: Released during apoptosis
• Nuclear accumulation: In late apoptosis
• Synaptic localization: Present at synapses

Neuronal Specificity

Why Neurons Are Particularly Vulnerable

Neuronal Apop

• **Death rec--

Animal Models

Knock

• Surviving mice show enhanced resistance to some apoptotic stimuli

• Brain-specific deletion
• Neuron-specific deletion
• Inducible models

• Neuronal overexpression models
• Fluorescent reporter models
• Dominant-negative mutants

Species Differences

• Rodents: Similar caspase-3 sequence and function
• Primates: High conservation
• Differences in regulation: Species-specific splicing

Clinical Implications

Diagnostic Applications

Therapeutic Implications

[@matsushita2005]

Comparative An### Common

• Common execution via caspase-3
• ### Disease-S

Future Directions

Emerging Therapeutic Approaches

• FRET-based sensors: Real-time activity monitoring
• CRISPR screening: - Single-cell sequencing: Cell-type specifi

Summary

Caspase- Neuroinflammation modulation

• Intercellul

• Cell-type specific effects
• Speci

• Identifying bi- Understanding cell-type specific functions
• Exploring combination therapies

References